Mckinley Capital Management LLC Gilead Sciences, Inc. Transaction History

Mckinley Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $138,194 - $161,198	-2,130 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$72.84 - $88.8 $62,642 - $76,368	860 Added 67.72%	2,130 $161,000
Q4 2017 Feb 08, 2018	SELL	$71.15 - $83.52 $62,327 - $73,163	-876 Reduced 40.82%	1,270 $91,000
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $2.15 Million - $2.55 Million	-29,844 Reduced 93.29%	2,146 $174,000
Q2 2017 Aug 14, 2017	BUY	N/A	31,990	31,990 $2.26 Million

1,925

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.